Julien Orts

Prof. Dr. Julien Orts

Pharmaceutical Sciences, University of Vienna, Vienna, Wien, Austria
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
GSGustav N Sundell
Gustav N Sundell
RARoland Arnold
Roland Arnold
MAMuhammad Ali
Muhammad Ali
PNPiangfan Naksukpaiboon
Piangfan Naksukpaiboon
Julien OrtsJulien Orts
Julien Orts
Ylva IvarssonYlva Ivarsson
Ylva Ivarsson
A key function of reversible protein phosphorylation is to regulate protein–protein interactions, many of which involve short linear motifs (3–12 amino acids). Motif‐based interactions are difficult to capture because of their often low‐to‐moderate affinities. Here, we describe phosphomimetic proteomic peptide‐phage display, a powerful method for simultaneously finding motif‐based interaction and pinpointing phosphorylation switches. We computationally designed an oligonucleotide library encoding human C‐terminal peptides containing known or predicted Ser/Thr phosphosites and phosphomimetic variants thereof. We incorporated these oligonucleotides into a phage library and screened the PDZ (PSD‐95/Dlg/ZO‐1) domains of Scribble and DLG1 for interactions potentially enabled or disabled by ligand phosphorylation. We identified known and novel binders and characterized selected interactions through microscale thermophoresis, isothermal titration calorimetry, and NMR. We uncover site‐specific phospho‐regulation of PDZ domain interactions, provide a structural framework for how PDZ domains accomplish phosphopeptide binding, and discuss ligand phosphorylation as a switching mechanism of PDZ domain interactions. The approach is readily scalable and can be used to explore the potential phospho‐regulation of motif‐based interactions on a large scale.

23 March 2016 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
Julien OrtsJulien Orts
Julien Orts
MWMarielle Aulikki Wälti
Marielle Aulikki Wälti
MMMay Marsh
May Marsh
LVLaura Vera
Laura Vera
AGAlvar Gossert
Alvar Gossert
RRRoland Riek
Roland Riek

11 February 2015 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
MWMarielle Aulikki Wälti
Marielle Aulikki Wälti
Julien OrtsJulien Orts
Julien Orts
BVBeat Vögeli
Beat Vögeli
SCSilvia Campioni
Silvia Campioni
Roland RiekRoland Riek
Roland Riek

25 May 2012 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
Julien OrtsJulien Orts
Julien Orts
BVBeat Vögeli
Beat Vögeli
Roland RiekRoland Riek
Roland Riek

1 September 2009 in Journal of Magnetic Resonance
Verified
Journal Article
Closed access
Julien OrtsJulien Orts
Julien Orts
CGChristian Griesinger
Christian Griesinger
TCTeresa Carlomagno
Teresa Carlomagno

10 May 2021 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
NANadide Altincekic
Nadide Altincekic
SKSophie Marianne Korn
Sophie Marianne Korn
NQNusrat Shahin Qureshi
Nusrat Shahin Qureshi
MDMarie Dujardin
Marie Dujardin
MNMartí Ninot-Pedrosa
Martí Ninot-Pedrosa
ASAndreas Schlundt
Andreas Schlundt
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.